We hypothesize that ACE2, MME, Ang-(1–7) and its receptor (Mas1) may be down regulated in response to glucocorticoid administration contributing to reduced blood flow and supply of nutrients to the fetus ultimately resulting in IUGR development and programming of diseases later in life. Here, ACE2 is linked to fetal growth restriction.